Hepatic Encephalopathy and Albumin Lasting Cognitive Improvement

Recruiting now · Phase 2 · Has a placebo group

Conditions studied: Cirrhosis, Hepatic Encephalopathy

In brief

Hypothesis: Improvement in cognitive dysfunction with IV albumin in patients with cirrhosis with prior HE and MHE lasts for several weeks after albumin infusion has ended, and is due to persistent improvement in inflammatory markers, endothelial dysfunction, albumin function and gut microbial changes. This will be a single-arm, single-blind sequential trial of IV 25% albumin and IV saline over 8 weeks with biological sampling and cognitive and health related quality of life (HRQOL) testing with each subject acting as their own control.

Key facts

Study ID
NCT06052176
Run by
Hunter Holmes Mcguire Veteran Affairs Medical Center
People needed
30
Starts
2023-11-02
Expected to finish
2026-12-01
Last updated by the study team
2026-04-08

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.